Safety and Efficacy of Ziv Aflibercept in Myopic Choroidal Neovascularisation ,Central Retinal Vein Occlusion and Resistant Diabetic Macular Edema
Latest Information Update: 12 Oct 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Central retinal vein occlusion; Choroidal neovascularisation; Diabetic macular oedema; Myopia
- Focus Therapeutic Use
Most Recent Events
- 04 Mar 2020 New trial record